- About
- Admissions
- Academics
- Student Life
- Faculty & Research
- Alumni & Friends
Faculty Member:
| Title | Correlates of HIV-1 viral suppression in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam |
| Publication Type | Journal Article |
| Year of Publication | 2009 |
| Authors | Jordan MR, La H, Nguyen HD, Sheehan H, Lien TTM, Duong DV, Hellinger J, Wanke CA, Tang AM |
| Journal | International Journal of STD & AIDS |
| Volume | 20 |
| Pagination | 418–422 |
| ISSN | 0956-4624 |
| Keywords | Adult, Cohort Studies, Combination, Drug Therapy, Drug Users, Male, Patient Compliance, Reverse Transcriptase Inhibitors, Treatment Outcome, Vietnam, Viral Load, Young Adult, {Anti-HIV} Agents, {HIV-1, {HIV} Infections, {Substance-Related} Disorders, } Humans |
| Abstract | Injection drug users bear the burden of HIV in Vietnam and are a focus of national treatment programmes. To date, determinants of successful therapy in this population are unknown. Substance use and clinical correlates of viral suppression were studied in 100 HIV-1-infected drug users receiving antiretroviral therapy (ART) for at least six months in Hanoi, Vietnam. The mean age of the cohort was 29.9 + 4.9 years; all were men. A majority of patients (73%) achieved viral suppression (HIV-RNA <1000 copies/mL). Correlates of viral suppression include self-reported > or = 95% adherence (P < 0.01) and current use of trimethoprim/sulphamethoxazole (P < 0.01); current or ever diagnosed with tuberculosis was associated with viral non-suppression (P = 0.006). Tobacco use was prevalent (84%), and surprisingly 48% of patients reported active drug use; neither was associated with viral non-suppression. This is the first study to document successful ART treatment in a population of Vietnamese drug users; rates of viral suppression are comparable to other international populations. The 28% of patients without HIV-1 suppression highlight the need for adherence promotion, risk reduction programmes, and population-based surveillance strategies for assessing the emergence of HIV drug resistance in settings where access to viral load and drug resistance testing is limited. |
| URL | http://www.ncbi.nlm.nih.gov/pubmed/19451329 |
| DOI | 10.1258/ijsa.2008.008389 |


